Startups
Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.
Overview
Location
United Kingdom
Total raised
$1.33M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 10, 2026 | Nscale secures $1.4B, Proxima Fusion lands €411M, and Invest Europe sees VC rebound | This week, we tracked more than 70 tech funding deals worth over €2.8 billion and over 5 exits, M&A transactions, rumours, and related news stories across Europe. Alongside the week’s top funding rounds, we’ve highlighted key industry d... |
| Jul 8, 2026 | Respiro Diagnostics secures £1M to advance lung diagnostics | Respiro Diagnostics, a UK-based startup developing breath-based diagnostics for lung diseases, has raised £1 million in a pre-seed funding round led by Zinc Venture Capital and SFC Capital. The round also included participation from Amadeus... |
| Respiro Diagnostics | “Respiro is harnessing insights from the breath to detect lung cancer earlier, non-invasively, and without scans or radiation. Built for use in everyday care settings.” |
Reviews 0
FAQ about Advancing breath
How much funding has Advancing breath raised?
Advancing breath has raised $1.33M in total across 1 funding round.
What has the press written about Advancing breath?
Parsers VC has collected 4 articles mentioning Advancing breath, among them “Nscale secures $1.4B, Proxima Fusion lands €411M, and Invest Europe sees VC rebound” (Jul 10, 2026) and “Respiro Diagnostics secures £1M to advance lung diagnostics” (Jul 8, 2026).
Is Advancing breath still active?
Yes, Advancing breath is active; its latest activity on Parsers VC dates from Jul 13, 2026.